Next Article in Journal
A Comparative Study on Extraction and Physicochemical Properties of Soluble Dietary Fiber from Glutinous Rice Bran Using Different Methods
Next Article in Special Issue
Rilpivirine and Dolutegravir Simultaneously Measured via RP-HPLC-PDA with Box–Behnken Design Application: A Study of Forced Degradation under Various Conditions
Previous Article in Journal
Functionalization of Sodium Magnesium Silicate Hydroxide/Sodium Magnesium Silicate Hydrate Nanostructures Using 2,3-Dihydroxybenzaldehyde as a Novel Nanocomposite for the Efficient Removal of Cd(II) and Cu(II) Ions from Aqueous Media
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Pharmacognostical and Phytochemical Evaluation of a Unani Polyherbal Formulation: Dawa ul Kurkum by HPTLC

1
Amity Institute of Pharmacy, Amity University, Noida 201301, Uttar Pradesh, India
2
Department of Ilmul Advia, School of Unani Medical Education and Research, Jamia Hamdard University, New Delhi 110062, Delhi, India
3
VC Office, Era University, Sarfaraz Ganj, Hardoi Road, Lucknow 226003, Uttar Pradesh, India
4
Department of Clinical Pharmacy, College of Pharmacy King Saud University, Riyadh 11451, Saudi Arabia
5
Department of Immunology and Microbiology, Biomedical Research, The University of Texas, Rio Grande Valley, 5300 North L Street, McAllen, TX 78504, USA
*
Author to whom correspondence should be addressed.
Separations 2023, 10(2), 89; https://doi.org/10.3390/separations10020089
Submission received: 10 January 2023 / Revised: 22 January 2023 / Accepted: 24 January 2023 / Published: 28 January 2023

Abstract

:
Background: Dawa ul Kurkum (Duk) is a widely used Unani formulation. It consists of seven plant herbs, including stigmas of Crocus sativus L., rhizomes of Nardostachys jatamansi (D.Don) DC., the bark of Cinnamomum cassia (L.) J. Presl., shoot of Cymbopogon jwarancusa (Jones ex Roxb.) Schult., the resin of Commiphora wightii (Arn.) Bhandari, roots of Saussurea lappa (Decne.) Sch.Bip., and bark of Cinnamomum zeylanicum Blume. However, no study has been previously conducted to characterize this formulation. Thus, the present study was designed to carry out the pharmacognostic and phytochemical characterization of Duk. Methods: Duk was prepared following the protocols in Bayaz e Kabeer and The National Formulary of Unani Medicine Part-I. The characterization included organoleptic properties, fluorescence analysis, preliminary phytochemical screening, antioxidant activity, and active constituent profiling using HPTLC. Results: Evaluation of Duk showed the presence of carbohydrates, flavonoids, quinones, glycosides, cardiac glycosides, terpenoids, phenols, coumarin, steroids, and phytosterols. The total phenolic and flavonoid content was 5.75 ± 0.23 mg GAE/g and 10 ± 0.18 mg QUE/g, respectively. HPTLC of Duk showed the presence of p-coumaric acid, cinnamaldehyde, citral, crocin, isovaleric acid, guggulsterone, and dehydrocostus lactone. Conclusions: Our findings supported the use of Duk as a conventional medicine, and these results could be used as a reference for the standardization of Duk.

Graphical Abstract

1. Introduction

In the last century, medical science has made remarkable advances worldwide. Overall mortality rates have reduced, life expectancy has improved, several new life-saving pharmaceuticals have been developed to aid in the battle against various infectious and other illnesses, and technological advancements have expanded the potential of contemporary science. Despite these incredible advancements and modernization in healthcare, quality treatment and its benefits have still not reached every door of the world [1]. The majority of the world’s population, mostly in poor and underdeveloped nations, lacks access to modern medicine and relies on time-tested traditional/alternative or complementary systems of care [2,3].
Complementary and alternative healthcare and medical practices (CAM) are a varied set of medical and healthcare systems, procedures, and products that are currently not considered a part of modern medicine. Complementary medicine refers to therapies that supplement standard allopathic medicine and are used in conjunction with current treatments. Alternative medicine refers to therapeutic techniques utilized instead of standard medicine to treat or improve illness outcomes. The fundamental principle of complementary and alternative medicine includes holistic treatment, which focuses on treating the individual [4]. The “WHO Traditional Medicine Strategy 2014–2023” clearly emphasizes the integration of traditional and complementary medicine to ensure qualitative, safer, effective, and universal healthcare [5]. In recent years, these approaches have gained enormous attention as they are safer, more reliable, and more cost-effective than synthetic forms of treatment [6,7]. Mainstreaming such medicinal plants is important as they offer fewer side effects and are rich in various secondary metabolites including alkaloids, flavonoids, glycosides, tannins, steroids, and saponins [7]. These metabolites are mainly responsible for their pleiotropic therapeutic effects, including anti-cancer activity [8].
Dawa ul Kurkum (Duk) is one such Unani polyherbal formulation, containing the stigma of Crocus sativa L., roots of Nardostachys jatamansi (Jones ex Roxb.) Schult. and Saussurea lappa (Decne.) Sch.Bip., the bark of Cinnamomum cassia (L.) J. Presl and Cinnamomum zeylanicum Blume, the aerial parts of Cymbopogon jwarancusa (Jones ex Roxb.) Schult., and the resin of Commiphora wightii (Arn.) Bhandari (Figure 1). It is prescribed by Unani practitioners for spleen disorders, liver dysfunction, anorexia, abdominal pain, ascites, and dropsy and is used as a renal, liver, and urinary bladder tonic and carminative [9,10]. The literature also reflects the hepatoprotective and immunomodulatory activity of Duk [11,12].
The name “Duk” is due to its main ingredient Kurkum (Saffron gynacium). Saffron, a well-known spice, is widely used in human nutrition, cosmetics, perfumery, and as a dye. High-quality saffron contains approximately 30% crocins, 5 to 15% picrocrocin, and normally up to 2.5% volatile ingredients such as safranal. Along with these major bioactive components, various other anthocyanins and flavonol glycosides have also been reported in various species of this genus [13]. Traditionally, saffron is used as an anti-inflammatory, antioxidant, anti-cancer, anti-depressant, anti-convulsant, hepatoprotective, neuroprotective, nephroprotective, cardioprotective, mutagenic and aphrodisiac agent [14,15,16,17,18]. Other constituents of Duk are also widely used due to their active constituents and pleiotropic properties. Jatamansi is used as a good stimulant, antispasmodic, tonic, laxative, and anti-epileptic and has been used in the treatment of a wide range of disorders, including the digestive system, circulatory system, nervous system, respiratory system, urinary system, reproductive system, and skin diseases [19]. These properties of jatamansi are mainly due to the presence of jatamansone, nardostachone, isovaleric acid, nardin, nardal, jatamnsic acid, spirojatamol, and various other active constituents [20]. Cinnamon is widely used in food preparations and industrial products such as candies, chewing gums, mouthwash and toothpaste. Cinnamon species exhibit various pharmacological activities, including antioxidant, antimicrobial, anti-inflammatory, anticancer, antidiabetic, wound healing, anti-HIV, anti-anxiety and antidepressant activities. It is also used to treat asthma, bronchitis, diarrhoea, headache, inflammation and cardiac disorders [21,22]. The essential oil of cinnamon is known to possess active constituents such as cinnamaldehyde, eugenol, caryophyllene, cinnamyl acetate and cinnamic acid [23]. In tribal areas, lemongrass is used as a flavouring agent for local cuisines. Moreover, the plant has also been used in traditional medicine as a blood purifier and in the treatment of rheumatism, cough, fever and cholera. Lemongrass contains active constituents such as citral, piperitone, δ-2-carene, α-phellandrene, citronellal, geranial and neral [24]. The major chemical constituents of guggul are z-guggulsterone, e-guggulsterone, guggul lignans, gugglu tetrols, mukulol, allylcembrol, z-guggulusterol, and e-guggulusterol, and it is used in digestive ailments, such as anorexia, flatulence, worm infestations, and piles [25]. Costus is known for its hepatoprotective, hypo-glycaemic, hypo-lipidemic, hypotensive and vaso-relaxing effect, anti-diabetic, anti-inflammatory, anti-microbial, antifeedant, anti-parasitic, anti-spasmodic, anti-ulcer and cholagogic, anti-cancer/tumour, immunomodulator, and bronchitic effects. The pharmacological activity of this plant is attributed to its active components: saussurine, costunolide, and dehydrocostus lactone [26].
Despite the varied use of Duk and its herbal components, no study has ever been conducted to explore this formulation on pharmacognostic grounds. Thus, the current investigation is aimed at assessing the physio- and phyto-chemical aspects of this formulation.

2. Materials and Methods

2.1. Collection of Plant Material, Drug Authentication, and Preparation of Duk

All the dried herbal drugs were purchased from Khari Bawli, Delhi, India (Table 1). The drugs were authenticated from NISCAIR, New Delhi, India and their voucher numbers provided were: Cinnamomum cassia (L.) J. Presl—NISCAIR/RHMD/Consult/2018/3156-05-6, Cinnamomum zeylanicum Blume—NISCAIR/RHMD/Consult/2018/3156-05-7, Cymbopogon jwarancusa (Jones ex Roxb.) Schult.—NISCAIR/RHMD/Consult/2018/3156-05-3, Crocus sativa L.—NISCAIR/RHMD/Consult/2018/3156-05-1, Commiphora wightii (Arn.) Bhandari—NISCAIR/RHMD/Consult/2018/3156-05-4, Nardostachys jatamansi (D.Don) DC.— NISCAIR/RHMD/Consult/2018/3156-05-2, and Saussurea lappa (Decne.) Sch.Bip.—NISCAIR/RHMD/Consult/2018/3156-05-5.
All the drugs (except Crocus sativus L., Commiphora wightii (Arn.) Bhandari and Cymbopogon jwarancusa (Jones ex Roxb.) Schult.) were crushed, ground, and sieved. Crocus sativus L. and Commiphora wightii (Arn.) Bhandari was crushed in a porcelain mortar pestle and Cymbopogon jwarancusa (Jones ex Roxb.) Schult. was ground using a mixer grinder.
Duk was prepared following the protocols of Bayaz e Kabeer and The National Formulary of Unani Medicine Part-I [9,10]. Briefly, a 70% ethanol extract was prepared from the powdered drugs by shaking and stirring at 50–60 rpm (RT, 24 h) and sonicating (30 min, <60 °C), and the extract was filtered (using Whatman no. 1). The total filtrate was concentrated using a rotary evaporator (65 °C, 100–110 rpm) and lyophilized to dryness. The dried powder was weighed and kept in airtight glass vials (4 °C) until further use.

2.2. Organoleptic Properties

The organoleptic property is the distinctive attributes or qualities of any drug perceived by sensory experiences. It refers to the evaluation of a drug based on its appearance, colour, odour, taste, and texture [27,28]. These properties were determined based on the methods mentioned by Wallis [29]. For the odour, a small amount of Duk was placed in a beaker and was slowly and repeatedly inhaled. The strength (none, weak, distinct, or strong) and sensation of odour (aromatic, fruity, rancid, musty, mouldy, etc.) were recorded. The taste was noted based on the classification as sweet, sour, pungent, bitter, astringent, or mucilaginous. The texture was recorded by gently placing the sample between the thumb and index finger and rubbing it.

2.3. Fluorescence Analysis

An amount of 1–2 mg Duk was placed on a microscope slide, and treated with different chemicals such as 1N NaOH (aqueous and alcoholic), 1N HCl, ammonia, 5% FeCl3, 5% iodine, acetic acid, 1N HNO3, and 1N H2SO4 and observed under daylight, short wave (254 nm) and long wave (366 nm) UV lights using a UV cabinet [30].

2.4. Preliminary Phytochemical Screening

The Duk was subjected to preliminary phytochemical screening to observe the presence or absence of phytoconstituents such as carbohydrates, tannins, saponins, alkaloids, quinones, glycosides, cardiac glycosides, terpenoids, phenols, coumarin, steroids & phytosterols, phlobatannins, flavonoids and anthraquinones by the standard methods [Table 2]. The screening was done for the presence or absence of phytochemicals using diagnostic procedures such as colour concentration or precipitate formation. The findings were qualitative, with a positive ‘+’ sign indicating the presence of phytochemicals and a negative ‘−’ sign indicating their absence.

2.5. Quantitative Phytochemical Analysis

2.5.1. Total Phenol Content (TPC)

The Folin–Ciocalteu reagent (FCR; SRL Pvt. Ltd., Pune, India) method was used to determine the total phenolic content of Duk. 500 μL of Duk solution (1 mg/mL) was mixed with 3.5 mL of distilled water and 250 μL of FCR in a test tube and the solution mixture was left for incubation for 8 min at room temperature. An amount of 750 μL of 20% sodium carbonate solution was added to the test tube and incubated for 2 h. Finally, the absorbance was taken at 765 nm using a UV-visible spectrophotometer (LabIndia Instruments Pvt. Ltd., Mumbai, India) against the blank. The procedure was repeated three times and the total phenolic content was expressed as gallic acid equivalent [31].

2.5.2. Total Flavonoid Content (TFC)

The aluminium chloride colorimetric method was used to determine the total flavonoid content of Duk. 500 μL of Duk solution (1 mg/mL) was mixed with 1.5 mL of methanol, 0.1 mL of 10% aluminium chloride, 0.1 mL of 1 M potassium acetate aqueous solution, and 2.8 mL of distilled water. The yellow colour confirmed the presence of flavonoids. The test sample was incubated for 30 min at room temperature and absorbance was taken at 415 nm against the blank. The procedure was repeated three times and results were expressed as mg quercetin/g dry weight [31].

2.6. Evaluation of Antioxidants

2.6.1. DPPH Radical Scavenging Assay

An amount of 0.1 mM of methanolic solution of 2,2-Diphenyl-1-picrylhydrazyl (DPPH; Central drug House Pvt. Ltd., Delhi, India) was added to different concentrations (5–60 μg/mL) of Duk. The mixtures were vortexed and allowed to rest in the dark (RT) for 30 min. The decrease in the absorbance was measured at 517 nm through a UV spectrophotometer [32]. Ascorbic acid (SRL Pvt. Ltd., Pune, India) was used as a positive control. Percentage inhibition of DPPH radical was calculated using the following equation:
% DPPH radical scavenging activity = {(ODcontrol − ODsample)/ODcontrol} × 100
where ODcontrol is the absorbance of the control and ODsample is the absorbance of the DuK/Ascorbic acid. Percentage inhibition was plotted against concentration. All experiments were performed in triplicate.

2.6.2. Ferrous Reducing Antioxidant Capacity (FRAC) Assay

An amount of 1 mL of Duk solution at different concentrations (100 μg/mL–6.4 mg/mL), 2.5 mL of potassium buffer (0.2 M), and 2.5 mL of 1% potassium ferricyanide solution were added into the test tubes. The reaction mixtures were incubated for 20 min at 50 °C to complete the reaction. After incubation, 2.5 mL of 10% trichloroacetic acid was added. Each mixture was centrifuged at 750 g for 10 min and 2.5 mL of supernatant was taken; to which 2.5 mL distilled water and 0.5 mL 0.1% ferric chloride solution was added. The solution mixture without Duk was treated as a blank. The absorbance was measured at 700 nm by a UV spectrophotometer against the blank. The experiment was repeated three times at each concentration [33].

2.7. Phytochemical Profiling of DuK through High-Performance Thin-Layer Chromatography (HPTLC)

A CAMAG TLC system composed of Camag Automatic TLC Sampler 4 (ATS4), TLC scanner 3, and win CATS 1.2.2 software (CAMAG CO., Muttenz, Switzerland) was used for HPTLC. Chromatography was performed on silica gel pre-coated aluminium plate 60 F254 plates (250 μm thickness; E. Merck, Darmstadt, Germany) using a mobile phase (mentioned in Table 3). The sample and standards (p-coumaric acid and guggulsterone: Natural Remedies Pvt. Ltd., Bangalore, India; dehydrocostus lactone, crocin, citral, and isovaleric acid: Sigma Aldrich Co. LLC., St. Louis, MO, USA; cinnamaldehyde: Tokyo Chemical Industry Co., Ltd., Chennai, Tamil Nadu, India) were spotted as bands of 6 mm width with a Camag 25 μL sampling syringe (Hamilton, Bonaduz, Switzerland) at an application rate of 50 nL/s. The plates were developed in twin trough development chambers. After development, the HPTLC plates were derivatized with anisaldehyde/vanillin sulfuric reagent and after drying; plates were heated in a hot air oven at 110 °C for 2 min.

3. Results & Discussion

3.1. Organoleptic Evaluation

The Indian subcontinent possesses the richest and most diverse flora of blooming medicinal plants. Most of the world’s population is primarily dependent on medicinal plants, with lifesaving pharmaceuticals being the most exceptional source. Approximately 80% of the world’s population is interested in using traditional medicine based on plant components, and medicinal plants play an essential role in human medical treatment. They continue to be a substantial and valuable aid in working on individual well-being and the improved treatment of various ailments. Indigenous medicines play an essential role in primary health care and, therefore, their scientific evaluation is required for proper utilization [34]. Therefore, our polyherbal formulation was subjected to some standardization variables, such as organoleptic properties. The results were: Duk was powder in form, rust iron in colour, slightly rough in texture, and has a characteristic odour and taste.

3.2. Fluorescence Analysis

Fluorescence analysis is another standardization parameter for plant-based drugs. It determines the constituents of herbal medications and provides information about their chemical composition. Under suitable illumination conditions, the chemical constituents exhibit a fluorescence that is specific to them. In the case where chemical constituents are non-fluorescent, treatment with different chemical reagents can be done to attain the property [35]. Duk exhibited different colours on treatment with different chemical reagents. The colours were identified and noted in Table 4.

3.3. Preliminary and Quantitative Phytochemical Screening and Antioxidant Activity of Duk

Since time immemorial, ethnomedicine has been widely used for the prevention and treatment of various diseases and disorders. The credit of this property can be attributed to the presence of various phytoconstituents and the antioxidant potential of these plants. Therefore, to support and expand the usage of Duk in traditional medicine systems, preliminary phytochemical screening and in vitro antioxidant activity were investigated [36]. It was observed that carbohydrates, flavonoids, quinones, glycosides, cardiac glycosides, terpenoids, phenols, coumarin, steroids and phytosterols were present in Duk, whereas tannins, saponins, alkaloids, phlobatannins, and anthraquinones were absent in Duk (Table 5). As estimated by the FCR method and aluminium chloride colorimetric method, the total phenolic and flavonoid content was found to be 5.75 ± 0.23 mg GAE/g and 10 ± 0.18 mg QUE/g, respectively.
Significant evidence has accumulated to indicate that reactive oxygen species (ROS) and other oxidants play essential roles in developing various illnesses and diseases. The findings have shifted scientists’ focus to an appreciation of antioxidants for disease prevention, therapy, and human health maintenance. The human body has an innate anti-oxidative system responsible for various biological activities, such as anti-mutagenic, anti-carcinogenic, and anti-ageing responses. Antioxidants stabilize or destroy free radicals frequently before they assault biological cell targets. Recently, there has been increasing interest in naturally occurring antioxidants because they are multifunctional and allow tremendous scope in rectifying ROS imbalance [37]. In the current study, the antioxidant activity of Duk has been assessed by DPPH and FRAP assay. DPPH solution measures the electron-donating ability of the herbal molecules. The activity is based upon the potential of natural products to decolourize the DPPH solution as the change in colour is directly proportional to the concentration of antioxidant [38]. In the present study, it was observed that the DPPH radical scavenging activity was positively correlated to the concentration of the extract. At 5 μg/mL, the percentage of scavenging activity of Duk was 16.30% and it rose to 53.60% at a concentration of 40 μg/mL. At concentrations above 40 μg/mL, we observed a slight decrease in the activity ending with saturation. In the case of ascorbic acid (positive control), the percentage of scavenging activity at 5 μg/mL was 33.95% and 75.48% at a concentration of 60 μg/mL. The results of Duk and ascorbic acid were comparable at a concentration of 30 μg/mL (Figure 2a). The reducing power of Duk measured by FRAP was positively correlated to the concentration. The presence of reductants in Duk reduces the Fe3+/ferricyanide complex to its ferrous form, thereby turning the yellow colour of the test solution to green [39]. Similar to the results obtained in the radical scavenging assay, the absorbance for the ferric reducing power of Duk increased from 0.10 to 3.75 at concentrations of 0.1 to 6.4 mg/mL (Figure 2b). The reducing power of Duk can be an indicator of its antioxidant potential.

3.4. HPTLC of Duk Showed the Presence of All Seven Principal Active Metabolites of Its Constituent Herbs

The pharmacological activity of any herbal mixture is made possible by the presence of active constituents in it. Therefore, it is crucial to separate these metabolites, as they could be of clinical significance. HPTLC is one such simple, robust, reproducible, and popular technique for the identification of secondary metabolites in herbal extracts [40,41,42]. Through HPTLC, we have confirmed the presence of the main phytoconstituents of the seven herbal constituents in the polyherbal formulation prepared by us and this is the first report of the qualitative characterization of DuK. Present HPTLC fingerprinting data can be helpful in the authentication and identification of these active constituents of DuK in the performed solvent system.
The composition of the mobile phase for all the active constituents was optimized by testing a variety of solvent mixtures of different polarities and adding minute amounts of an acid or base. Well-defined spots were obtained when the TLC chamber was saturated with the respective mobile phase for 30 min at 25 ± 2 °C and the plates were post-derivatized with a suitable reagent (Table 3). In HPTLC, the heights corresponding to the standards were seen at the desired Rf. A comparison of the characteristics of the height for standards and that of the sample (Figure 3) confirmed the presence of the main active constituents of the seven plants used to prepare Duk. These constituents are p-coumaric acid [Cinnamomum cassia (L.) J. Presl], cinnamaldehyde [Cinnamomum zeylanicum Blume], citral [Cymbopogon jwarancusa (Jones ex Roxb.) Schult.], crocin [Crocus sativus L.], isovaleric acid [Nardostachys jatamansi (D. Don) DC.], guggulsterone [Commiphora wightii (Arn.) Bhandari], and dehydrocostus lactone [Saussurea lappa (Decne.) Sch.Bip.].

4. Conclusions

The current study analyzed the organoleptic and phytochemical characteristics, antioxidant activity, and HPTLC fingerprint of the polyherbal formulation. Duk showed the presence of various phytochemicals and possessed significant levels of phenols and flavonoids. In addition, Duk showed a critical anti-oxidant impact. The HPTLC fingerprint showed the presence of active constituents, such as p-coumaric acid, cinnamaldehyde, citral, crocin, isovaleric acid, e- and z-guggulsterone and dehydrocostus lactone. These findings will help in the standardization of this Unani preparation, Duk.

Author Contributions

Conceptualization, M.G., S.S., T.N., A.S. and M.S. (Maryam Sarwat); Data curation, M.G. and S.S.; Formal analysis, M.G. and S.S.; Methodology, M.G., S.S. and M.S. (Maryam Sarwat); Project administration, M.G., T.N., A.S. and M.S. (Maryam Sarwat); Resources, M.S. (Maryam Sarwat); Software, A.A.; Supervision, S.A. and M.S. (Maryam Sarwat); Validation, T.N., A.S. and M.S. (Maryam Sarwat); Visualization, S.A., A.A. and M.S. (Mohammad Sikander); Writing—original draft, M.G.; Writing—review & editing, S.A., A.A., M.S. (Mohammad Sikander) and M.S. (Maryam Sarwat). All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by a grant from the Central Council for Research in Unani Medicine (CCRUM), New Delhi, India (Grant No. 3-31/2014-ccrum/Tech).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data generated from the study are clearly presented and discussed in the manuscript.

Acknowledgments

We would like to thank the team of the Indian Pharmacopoeia Commission (IPC), Ghaziabad, India for helping us carry out HPTLC. The authors would like to extend their sincere appreciation to the Researchers Supporting Project Number (RSP2023R350), King Saud University, Riyadh, Saudi Arabia.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Sen, S.; Chakraborty, R. Revival, modernization and integration of Indian traditional herbal medicine in clinical practice: Importance, challenges and future. J. Tradit. Complement. Med. 2017, 7, 234–244. [Google Scholar] [CrossRef] [PubMed]
  2. Gupta, P.; Shetty, H. Use of natural products for oral hygiene maintenance: Revisiting traditional medicine. J. Tradit. Complement. Med. 2018, 15, 1–5. [Google Scholar] [CrossRef] [PubMed]
  3. World Health Organization. The World Medicines Situation (No. WHO/EDM/PAR/2004.5). Available online: https://www.who.int/publications-detail-redirect/WHO-EDM-PAR-2004.5 (accessed on 15 March 2022).
  4. Tabish, S.A. Complementary and alternative healthcare: Is it evidence-based? Int. J. Health Sci. 2008, 2, 5–9. [Google Scholar]
  5. World Health Organization. WHO Traditional Medicine Strategy: 2014–2023. Available online: https://www.who.int/publications/i/item/9789241506096 (accessed on 15 March 2022).
  6. Keene, M.R.; Heslop, I.M.; Sabesan, S.S.; Glass, B.D. Complementary and alternative medicine use in cancer: A systematic review. Complement. Ther. Clin. Pract. 2019, 35, 33–47. [Google Scholar] [CrossRef] [PubMed]
  7. Sheth, P.A.; Pawar, A.T.; Mote, C.S.; More, C. Antianemic activity of polyherbal formulation, Raktavardhak Kadha, against phenylhydrazine-induced anemia in rats. J. Ayurveda Integr. Med. 2021, 12, 340–345. [Google Scholar] [CrossRef] [PubMed]
  8. Jones, E.; Nissen, L.; McCarthy, A.; Steadman, K.; Windsor, C. Exploring the use of complementary and alternative medicine in cancer patients. Integr. Cancer Ther. 2019, 18, 1–9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. National Formulary of Unani Medicine-I. Central Council for Research in Unani Medicine (CCRUM); Ministry of Health and Family Welfare, Department of AYUSH: New Delhi, India, 2006; p. 88.
  10. Kabiruddin, M. Bayaz e Kabeer-II; Shaikh Mohammad Bashir and Sons: Lahore, Pakistan, 2018; p. 354. [Google Scholar]
  11. Reshi, M.R.; Gulati, K.; Naqvi, M.; Hassan, N.; Ray, A. Hepatoprotective Effects of Dawa-Ul-Kurkum, A Unani Polyherbal Preparation and the Possible Mechanisms in Experimental Model of Ethanol Induced Liver Damage in Rats. J. Pharm. Pharmacol. Res. 2022, 6, 122–130. [Google Scholar] [CrossRef]
  12. Reshi, M.R.; Gulati, K.; Ray, A. Immunomodulation During Hepatoprotective Effects of Dawa-Ul-Kurkum in D-Galactosamine-Induced Liver Cirrhosis in Rats. Int. J. Toxicol. Pharmacol. Res. 2022, 12, 166–179. [Google Scholar]
  13. Srivastava, R.; Ahmed, H.; Dixit, R.K.; Saraf, S.A. Crocus sativus L.: A comprehensive review. Pharmacogn. Rev. 2010, 4, 200. [Google Scholar] [CrossRef] [Green Version]
  14. Khorasany, A.R.; Hosseinzadeh, H. Therapeutic effects of saffron (Crocus sativus L.) in digestive disorders: A review. Iran J. Basic Med. Sci. 2016, 19, 455–469. [Google Scholar]
  15. Finley, J.W.; Gao, S. A perspective on Crocus sativus L. (Saffron) constituent crocin: A potent water-soluble antioxidant and potential therapy for Alzheimer’s disease. J. Agric. Food Chem. 2017, 65, 1005–1020. [Google Scholar] [CrossRef]
  16. Karimi, E.; Oskoueian, E.; Hendra, R.; Jaafar, H.Z. Evaluation of Crocus sativus L. stigma phenolic and flavonoid compounds and its antioxidant activity. Molecules 2010, 15, 6244–6256. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Tamaddonfard, E.; Farshid, A.A.; Eghdami, K.; Samadi, F.; Erfanparast, A. Comparison of the effects of crocin, safranal and diclofenac on local inflammation and inflammatory pain responses induced by carrageenan in rats. Pharmacol. Rep. 2013, 65, 1272–1280. [Google Scholar] [CrossRef] [PubMed]
  18. Razavi, B.M.; Hosseinzadeh, H.; Movassaghi, A.R.; Imenshahidi, M.; Abnous, K. Protective effect of crocin on diazinon induced cardiotoxicity in rats in subchronic exposure. Chem.-Biol. Interact. 2013, 203, 547–555. [Google Scholar] [CrossRef] [PubMed]
  19. Kaur, H.; Lekhak, M.M.; Chahal, S.; Goutam, U.; Jha, P.; Naidoo, D.; Ochatt, S.J.; Kumar, V. Nardostachys jatamansi (D. Don) DC.: An invaluable and constantly dwindling resource of the Himalayas. S. Afr. J. Bot. 2020, 135, 252–267. [Google Scholar] [CrossRef]
  20. Jugran, A.K.; Rawat, S.; Bhatt, I.D.; Rawal, R.S. Valeriana jatamansi: An herbaceous plant with multiple medicinal uses. Phytother. Res. 2019, 33, 482–503. [Google Scholar] [CrossRef]
  21. Kumar, S.; Kumari, R.; Mishra, S. Pharmacological properties and their medicinal uses of Cinnamomum: A review. J. Pharm. Pharmacol. 2019, 71, 1735–1761. [Google Scholar] [CrossRef] [Green Version]
  22. Wang, J.; Su, B.; Jiang, H.; Cui, N.; Yu, Z.; Yang, Y.; Sun, Y. Traditional uses, phytochemistry and pharmacological activities of the genus Cinnamomum (Lauraceae): A review. Fitoterapia 2020, 146, 104675. [Google Scholar] [CrossRef] [PubMed]
  23. Pathak, R.; Sharma, H. A Review on Medicinal Uses of Cinnamomum verum (Cinnamon). J. Drug Deliv. Ther. 2021, 11, 161–166. [Google Scholar] [CrossRef]
  24. Avoseh, O.; Oyedeji, O.; Rungqu, P.; Nkeh-Chungag, B.; Oyedeji, A. Cymbopogon species; ethnopharmacology, phytochemistry and the pharmacological importance. Molecules 2015, 20, 7438–7453. [Google Scholar] [CrossRef]
  25. Kumar, S.; Shankar, V. Medicinal plants of the Indian desert: Commiphora wightii (Arnott) Bhand. J. Arid Environ. 1982, 5, 1–11. [Google Scholar] [CrossRef]
  26. Madhuri, K.; Elango, K.; Ponnusankar, S. Saussurea lappa (Kuth root): Review of its traditional uses, phytochemistry and pharmacology. Orient. Pharm. Exp. Med. 2012, 12, 1–9. [Google Scholar] [CrossRef]
  27. Aziz, N.; Wal, A.; Wal, P.; Pal, R.S. Preparation and evaluation of the polyherbal powder: The nature’s pharmacy for the treatment of diabetes mellitus and its complications. Pharmacophores 2019, 10, 60–70. [Google Scholar]
  28. Maurya, N.; Vishwakarma, R.; Bhanap, K.; Shah, S.; Patil, S. Preparation and quality evaluation of hingwashtak churna: A polyherbal formulation. J. Pharmacogn. Phytochem. 2020, 9, 1923–1927. [Google Scholar]
  29. Wallis, T.E. Text Book of Pharmacognosy, 5th ed.; CBS Publishers and Distributors: New Delhi, India, 2004. [Google Scholar]
  30. Sharma, B.; Bagchi, A.; Bhutia, S.; Sarkar, B.R.; Pal, P. Formulation and Evaluation of Expectorant activity of Poly Herbal Cough Syrup from Traditional Medicinal Plant extracts of North East India. Res. J. Pharm. Technol. 2022, 15, 949–953. [Google Scholar] [CrossRef]
  31. Chanthasri, W.; Puangkeaw, N.; Kunworarath, N.; Jaisamut, P.; Limsuwan, S.; Maneenoon, K.; Choochana, P.; Chusri, S. Antioxidant capacities and total phenolic contents of 20 polyherbal remedies used as tonics by folk healers in Phatthalung and Songkhla provinces, Thailand. BMC Complement. Altern. Med. 2018, 18, 1–11. [Google Scholar] [CrossRef]
  32. Rahim, N.F.; Muhammad, N.; Abdullah, N.; Talip, B.A.; Poh, K.H. The interaction effect and optimal formulation of selected polyherbal extracts towards antioxidant activity. Food Res. 2020, 4, 2042–2048. [Google Scholar] [CrossRef] [PubMed]
  33. Arawwawala, L.D.; Karunaratne, T.D.; Sugatharatana, K.; Ariyawansa, H.S.; De Silva, H.A. In vitro antioxidant activities of a poly herbal preparation: Sarasvatha Choorna. Free Radic. Antioxid. 2021, 11, 35–47. [Google Scholar] [CrossRef]
  34. Kumar, H.D.; Mannem, K. A comparison study of macroscopical and microscopical characteristics of powder of Haritaki: Terminalia chebula (pericarp), Yavani: Ttrachyspermum ammi (fruit), Ajmoda: Apium leptophyllum (fruit) and Sunthi: Zingiber officinalie (rhizome). Int. J. Ayurveda Pharma. Res. 2012, 3, 309–313. [Google Scholar]
  35. Subba, A.; Mandal, P. Pharmacognostic studies and in vitro antioxidant potential of traditional polyherbal formulation of west Sikkim with Asparagus Spp. Pharmacogn. J. 2015, 7, 348–355. [Google Scholar] [CrossRef] [Green Version]
  36. Shalini, K.; Ilango, K. Preliminary phytochemical studies, GC-MS analysis and in vitro antioxidant activity of selected medicinal plants and its polyherbal formulation. Pharmacogn. J. 2021, 13, 648–659. [Google Scholar] [CrossRef]
  37. Saeed, N.; Khan, M.R.; Shabbir, M. Antioxidant activity, total phenolic and total flavonoid contents of whole plant extracts Torilis leptophylla L. BMC Complement. Altern. Med. 2012, 12, 1–12. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Dutt, V.; Srivastav, S.; Mittal, S.; Haque, M.R. Determination of microbial load, total Phenolic and flavonoids contents in polyherbal formulation “yograj guggulu vati”. J. Drug Deliv. Ther. 2020, 10, 1–5. [Google Scholar] [CrossRef] [Green Version]
  39. Müller, L.; Fröhlich, K.; Böhm, V. Comparative antioxidant activities of carotenoids measured by ferric reducing antioxidant power (FRAP), ABTS bleaching assay (αTEAC), DPPH assay and peroxyl radical scavenging assay. Food Chem. 2011, 129, 139–148. [Google Scholar] [CrossRef]
  40. Gökbulut, A. High Performance Thin Layer Chromatography (HPTLC) for the investigation of medicinal plants. Curr. Anal. Chem. 2021, 17, 1252–1259. [Google Scholar] [CrossRef]
  41. Ahmad Dar, A.; Sangwan, P.L.; Kumar, A. Chromatography: An important tool for drug discovery. J. Sep. Sci. 2020, 43, 105–119. [Google Scholar] [CrossRef]
  42. Girme, A.; Ghule, C.; Gaikar, N.; Hingorani, L. Rapid and sensitive High-Performance Thin-Layer Chromatographic (HPTLC) method for identification and quantification of luteolin by densitometry in Kasamarda (Cassia occidentalis L.). Indian J. Tradit. Knowl. 2021, 20, 700–706. [Google Scholar]
Figure 1. Representative pictures of the ingredients of our polyherbal formulation Duk.
Figure 1. Representative pictures of the ingredients of our polyherbal formulation Duk.
Separations 10 00089 g001
Figure 2. Antioxidant activity of Duk as evaluated with (a) DPPH, and (b) FRAP assays.
Figure 2. Antioxidant activity of Duk as evaluated with (a) DPPH, and (b) FRAP assays.
Separations 10 00089 g002
Figure 3. High-performance thin-layer chromatography and marker-based standardization of p-coumaric acid, cinnamaldehyde, citral, crocin, isovaleric acid, guggulsterone and dehydrocostus lactone in the developed polyherbal formulation. Red arrows shows the presence of the particular active constituent in the respective lane.
Figure 3. High-performance thin-layer chromatography and marker-based standardization of p-coumaric acid, cinnamaldehyde, citral, crocin, isovaleric acid, guggulsterone and dehydrocostus lactone in the developed polyherbal formulation. Red arrows shows the presence of the particular active constituent in the respective lane.
Separations 10 00089 g003
Table 1. Composition of Duk.
Table 1. Composition of Duk.
S. No.Biological Name of the DrugCommon Name/
Unani Name
Part of the PlantWeight (g)Used/
50 g
1.Cinnamomum cassia (L.) J. PreslChinese cinnamon/
Taj Qalmi
Bark10
2.Cinnamomum zeylanicum BlumeTrue cinnamon/DarchiniBark5
3.Cymbopogon jwarancusa (Jones ex Roxb.) Schult.Lemongrass/IzkharAerial part5
4.Crocus sativa L.Saffron/ZafranStigma10
5.Commiphora wightii (Arn.) BhandariGuggul/MurmakkiResin5
6.Nardostachys jatamansi (D.Don) DC.Jatamansi/ SumbuluttibRoot10
7.Saussurea lappa (Decne.) Sch.Bip.Costus/QustRoot5
Table 2. Identification test for the preliminary phytochemical screening of Duk.
Table 2. Identification test for the preliminary phytochemical screening of Duk.
S. No.Test forProcedureObservation for the Presence
1.Carbohydrates2 mL of Duk solution + 1 mL of Molisch’s reagent + Few drops of concentrated sulphuric acidPurple or reddish colour
2.Tannins1 mL Duk solution + 2 mL of 5% ferric chlorideDark blue or greenish colour
3.Saponins2 mL of Duk solution + 2 mL of distilled water; Shake for 15 min1 cm layer of foam
4.Flavonoids2 mL of Duk solution + 1 mL of 2N sodium hydroxideYellow colour
5.Alkaloids2 mL of Duk solution + 2 mL of concentrated hydrochloric acid + Few drops of Mayer’s reagent Green colour or white precipitate
6.Quinones1 mL Duk solution + 1 mL of concentrated sulphuric acidRed colour
7.Glycosides2 mL of Duk solution + 3 mL of chloroform + 10% ammonia solutionPink colour
8.Cardiac glycosides0.5 mL of Duk solution + 2 mL of glacial acetic acid + Few drops of 5% ferric chloride + 1 mL of concentrated sulphuric acidBrown ring at the interface
9.Terpenoids0.5 mL of Duk solution + 2 mL of chloroform + concentrated sulphuric acidRed brown colour at the interface
10.Phenols1 mL Duk solution + 2 mL of distilled water + Few drops of 10% ferric chlorideBlue or green colour
11.Coumarins1 mL Duk solution + 1 mL of 10% NaOHYellow colour
12.Steroids and phytosterols1 mL Duk solution + 1 mL of chloroform + Few drops of concentrated sulphuric acidBrown ring: Steroids
Bluish brown ring: Phytosterols
13.Phlobatannins1 mL Duk solution + Few drops of 2% HClRed colour precipitate
14.Anthraquinones1 mL Duk solution + 10% ammonia solutionPink colour precipitate
Table 3. Optimization and validation for the presence of the principal active components in the polyherbal formulation Duk through HPTLC.
Table 3. Optimization and validation for the presence of the principal active components in the polyherbal formulation Duk through HPTLC.
S. No.Active ConstituentSolvent SystemRatioApplication VolumeIllumination Rf ValuePost-Chromatographic Derivatization
StandardDuk
1.p-Coumaric acid Toluene: Ethyl Acetate: Formic Acid8:2:0.525 μL15 μL254 nm0.28Anisaldehyde Sulfuric Reagent
2.CinnamaldehydeToluene: Ethyl Acetate9.5:0.515 μL10 μL254 nm0.48Vanillin Sulfuric Reagent
3.Citral Toluene: Ethyl Acetate9.7:0.315 μL15 μL366 nm0.62Vanillin Sulfuric Reagent
4.Crocinn-Butanol: Water: Acetic acid4:1:115 μL10 μL366 nm0.28Anisaldehyde Sulfuric Reagent
5.Guggulsterone Hexane: Ethyl Acetate: Acetic Acid75:25:0.510 μL10 μL366 nmz: 0.39
e: 0.29
Anisaldehyde Sulfuric Reagent
6.Isovaleric acid Toluene: Acetone9:115 μL15 μL366 nm0.11Anisaldehyde Sulfuric Reagent
7.Dehydrocostus lactoneToluene: Ethyl Acetate9:120 μL20 μL366 nm0.56Anisaldehyde Sulfuric Reagent
Table 4. Fluorescence analysis of the polyherbal formulation Duk.
Table 4. Fluorescence analysis of the polyherbal formulation Duk.
S. No.Treatment ConditionsDaylightUV Light
254 nm366 nm
1.Duk as suchReddish orangeRust BrownBlackish-brown
2.Duk + 1N NaOH (aq.)Brownish-yellowBrownBlackish-brown
3.Duk + 1N NaOH (alc.)Reddish-brownReddish-brownBlackish-brown
4.Duk + 1N HClDeep orangeDark orangeBrown
5.Duk + NH3Light brownLight brownBrown
6.Duk + 5% IodineDeep brownBrown Brown
7.Duk + 5% FeCl3Blackish-brownBrownish-blackBlack
8.Duk + Acetic aidBrownish-orangeBrownish-orangeBlackish- orange
9.Duk + 1N H2SO4Orange Reddish-brownBlackish-brown
10.Duk + 1N HNO3Yellowish-orangeReddish-orangeReddish-black
Table 5. Preliminary screening for the presence of secondary metabolites in DuK.
Table 5. Preliminary screening for the presence of secondary metabolites in DuK.
S. No.Phytochemical TestsDuk
1.Carbohydrates+ve
2.Tannins−ve
3.Saponins−ve
4.Flavonoids+ve
5.Alkaloids−ve
6.Quinones+ve
7.Glycosides+ve
8.Cardiac glycosides+ve
9.Terpenoids +ve
10.Phenols+ve
11.Coumarins +ve
12.Steroids and phytosterolsPhytosterols
13.Phlobatannins−ve
14.Anthraquinones−ve
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Gupta, M.; Sumaiya, S.; Ali, S.; Naved, T.; Sharma, A.; Ahmad, A.; Sikander, M.; Sarwat, M. Pharmacognostical and Phytochemical Evaluation of a Unani Polyherbal Formulation: Dawa ul Kurkum by HPTLC. Separations 2023, 10, 89. https://doi.org/10.3390/separations10020089

AMA Style

Gupta M, Sumaiya S, Ali S, Naved T, Sharma A, Ahmad A, Sikander M, Sarwat M. Pharmacognostical and Phytochemical Evaluation of a Unani Polyherbal Formulation: Dawa ul Kurkum by HPTLC. Separations. 2023; 10(2):89. https://doi.org/10.3390/separations10020089

Chicago/Turabian Style

Gupta, Meenakshi, Sajida Sumaiya, Sher Ali, Tanveer Naved, Archana Sharma, Ajaz Ahmad, Mohammed Sikander, and Maryam Sarwat. 2023. "Pharmacognostical and Phytochemical Evaluation of a Unani Polyherbal Formulation: Dawa ul Kurkum by HPTLC" Separations 10, no. 2: 89. https://doi.org/10.3390/separations10020089

APA Style

Gupta, M., Sumaiya, S., Ali, S., Naved, T., Sharma, A., Ahmad, A., Sikander, M., & Sarwat, M. (2023). Pharmacognostical and Phytochemical Evaluation of a Unani Polyherbal Formulation: Dawa ul Kurkum by HPTLC. Separations, 10(2), 89. https://doi.org/10.3390/separations10020089

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop